Dabigatran - A case history demonstrating the need for comprehensive approaches to optimize the use of new drugs

  1. Malmström, R.E.
  2. Godman, B.B.
  3. Diogene, E.
  4. Baumgärte, C.
  5. Bennie, M.
  6. Bishop, I.
  7. Brzezinska, A.
  8. Bucsics, A.
  9. Campbell, S.
  10. Ferrario, A.
  11. Finlayson, A.E.
  12. Fürst, J.
  13. Garuoliene, K.
  14. Gomes, M.
  15. Gutiérrez-Ibarluzea, I.
  16. Haycox, A.
  17. Hviding, K.
  18. Herholz, H.
  19. Hoffmann, M.
  20. Jan, S.
  21. Jones, J.
  22. Joppi, R.
  23. Kalaba, M.
  24. Kvalheim, C.
  25. Laius, O.
  26. Langner, I.
  27. Lonsdale, J.
  28. Lööv, S.-A.
  29. Malinowska, K.
  30. McCullagh, L.
  31. Paterson, K.
  32. Markovic-Pekovic, V.
  33. Martin, A.
  34. Piessnegger, J.
  35. Selke, G.
  36. Sermet, C.
  37. Simoens, S.
  38. Tulunay, C.
  39. Tomek, D.
  40. Voncina, L.
  41. Vlahovic-Palcevski, V.
  42. Wale, J.
  43. Wilcock, M.
  44. Wladysiuk, M.
  45. Van Woerkom, M.
  46. Zara, C.
  47. Gustafsson, L.L.
  48. Show all authors +
Journal:
Frontiers in Pharmacology

ISSN: 1663-9812

Year of publication: 2013

Volume: 4 MAY

Type: Article

DOI: 10.3389/FPHAR.2013.00039 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus